We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-7.3%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
-$23.5M
Cap. Flow
+$96.6K
Cap. Flow %
0.05%
Top 10 Hldgs %
12.17%
Holding
270
New
6
Increased
10
Reduced
8
Closed
11

Top Buys

Rank Stock Value
1
BBWI icon
Bath & Body Works
BBWI
+$1.56M
2
AKAM icon
Akamai
AKAM
+$979K
3
CRM icon
Salesforce
CRM
+$970K
4
NVDA icon
NVIDIA
NVDA
+$869K
5
OPK icon
Opko Health
OPK
+$814K

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$1.03M
2
BFH icon
Bread Financial
BFH
+$927K
3
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$923K
4
AIR icon
AAR Corp
AIR
+$862K
5
AMAT icon
Applied Materials
AMAT
+$721K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.53%
2 Healthcare 15.15%
3 Technology 13.83%
4 Industrials 12.02%
5 Financials 11.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMSA
226
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$265K 0.13%
98,054
– –
FCX icon
227
Freeport-McMoran
FCX
$86.2B
$264K 0.13%
27,210
– –
ARIA
228
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$263K 0.13%
45,105
– –
NTCT icon
229
NETSCOUT
NTCT
$2.83B
$262K 0.13%
7,411
– –
CPHD
230
DELISTED
Cepheid Inc
CPHD
$256K 0.13%
5,664
– –
MGNX icon
231
MacroGenics
MGNX
$233M
$246K 0.12%
11,484
– –
CWEI
232
DELISTED
Clayton Williams Energy, Inc.
CWEI
$233K 0.12%
6,000
– –
SNCR
233
DELISTED
Synchronoss Technologies
SNCR
$228K 0.12%
772
– –
KYNB
234
Kyntra Bio
KYNB
$27.4M
$227K 0.12%
414
– –
SMCI icon
235
Super Micro Computer
SMCI
$16.6B
$216K 0.11%
79,290
– –
IRWD icon
236
Ironwood Pharmaceuticals
IRWD
$586M
$215K 0.11%
24,651
– –
FORR icon
237
Forrester Research
FORR
$199M
$211K 0.11%
6,700
– –
IONS icon
238
Ionis Pharmaceuticals
IONS
$8.93B
$208K 0.11%
5,150
– –
AGIO icon
239
Agios Pharmaceuticals
AGIO
$2.08B
$200K 0.1%
2,835
– –
OCUL icon
240
Ocular Therapeutix
OCUL
$1.83B
$186K 0.09%
13,211
– –
ENV
241
DELISTED
ENVESTNET, INC.
ENV
$174K 0.09%
5,795
– –
GPRO icon
242
GoPro
GPRO
$120M
$172K 0.09%
+5,500
New +$271K
IDT icon
243
IDT Corp
IDT
$1.67B
$169K 0.09%
16,728
– –
HCR
244
DELISTED
Hi-Crush Inc. Common Stock
HCR
$167K 0.08%
22,321
– –
EQR icon
245
Equity Residential
EQR
$25.8B
$164K 0.08%
2,180
– –
OSPN icon
246
OneSpan
OSPN
$584M
$155K 0.08%
9,123
– –
MNKD icon
247
MannKind Corp
MNKD
$1.19B
$154K 0.08%
9,602
– –
BXP icon
248
Boston Properties
BXP
$11.6B
$144K 0.07%
1,213
– –
PLD icon
249
Prologis
PLD
$136B
$142K 0.07%
3,640
– –
SGMO
250
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$132K 0.07%
23,413
– –
7 8 9
10
11

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Capital Impact Advisors held 270 positions worth $197M, down 11% from $220M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors's Q3 2015 filing shows 6 new, 10 increased, 8 reduced and 11 closed positions. Its largest new stake was Opko Health: 61,537 shares worth $518K. The largest sale was Cognizant, an estimated $1.03M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

  • Capital Impact Advisors's largest Q3 2015 buy was Opko Health: 61,537 shares worth $518K.
  • Capital Impact Advisors added most to Bath & Body Works in Q3 2015, an estimated $1.56M increase.
  • Capital Impact Advisors's biggest Q3 2015 reduction was Brown-Forman Class B, cutting an estimated $554K.
  • Capital Impact Advisors fully exited Cognizant in Q3 2015, selling an estimated $1.03M.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $197M portfolio in Q3 2015.
  • Capital Impact Advisors opened 6 new positions and closed 11 in Q3 2015.
  • Capital Impact Advisors's portfolio value fell 11% quarter-over-quarter to $197M.

Based on Capital Impact Advisors's 13F filing for Q3 2015, filed 7 Oct 2015.